{"id":943,"date":"2024-12-30T08:35:17","date_gmt":"2024-12-30T08:35:17","guid":{"rendered":"https:\/\/psoriasisarthritis.ch\/?p=943"},"modified":"2024-12-30T08:48:20","modified_gmt":"2024-12-30T08:48:20","slug":"seronegativer-ana-wert-was-nun","status":"publish","type":"post","link":"https:\/\/psoriasisarthritis.ch\/?p=943","title":{"rendered":"Seronegativer ANA-Wert: Was nun?"},"content":{"rendered":"<p class=\"cvGsUA direction-ltr align-start para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Wenn trotz negativem ANA-Wert eindeutige Symptome einer erkrankung vorliegen, muss tiefergehend gesucht werden. <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Um einen \u00dcberblick zu erhalten, welche m\u00f6glichkeiten noch bestehen, um mit ANA assoziierte Erkrankungen nachzuweisen habe ich in diesem Beitrag <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">weitere Untersuchungsm\u00f6glichkeiten <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">aufgef\u00fchrt.<\/span><\/p>\n<p><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">1.Mit ANA assoziierte <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Autoimmunerkrankungen<\/span><\/strong><\/p>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Antiphospholipidsyndrom (APS)<\/span><\/strong><\/p>\n<ul>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Mit ANA assoziiert: <\/span><\/strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Bei etwa 10% der Patienten k\u00f6nnen ANA nachweisbar sein. APS ist eine Autoimmunerkrankung, die durch thrombophile Antik\u00f6rper gekennzeichnet ist, welche das Risiko f\u00fcr Thrombosen und Fehlgeburten erh\u00f6ht.<\/span><\/li>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zus\u00e4tzliche Blutwerte:<\/span><\/strong>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-Cardiolipin-Antik\u00f6rper: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Typisch f\u00fcr APS.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Beta-2-Glykoprotein-I-Antik\u00f6rper: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Wichtiger Marker.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Lupus-Antikoagulans: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zur Diagnose essenziell.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">D-Dimere: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Bei akuter Thrombose h\u00e4ufig erh\u00f6ht.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Autoimmune Hepatitis (AIH)<\/span><\/strong><\/p>\n<ul>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Mit ANA assoziiert: <\/span><\/strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">ANA sind bei 50-80% der Patienten mit AIH nachweisbar, besonders bei Typ I (lupoide Hepatitis).<\/span><\/li>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zus\u00e4tzliche Blutwerte:<\/span><\/strong>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-glattmuskul\u00e4re Antik\u00f6rper (SMA):<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> H\u00e4ufig bei Typ I AIH.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-LKM1: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Spezifisch f\u00fcr Typ II AIH.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Leberwerte (ALT, AST, ALP):<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Erh\u00f6ht bei Leberentz\u00fcndung.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">IgG:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Oft erh\u00f6ht und ein diagnostischer Hinweis.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Autoimmunhepatitis Typ I (lupoide Hepatitis)<\/span><\/strong><\/p>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"><strong>Mit ANA assoziiert:<\/strong> <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Bei nahezu 100% der Patienten sind ANA positiv. Dies ist die h\u00e4ufigste Form der Autoimmunhepatitis.<\/span><\/li>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zus\u00e4tzliche Blutwerte:<\/span><\/strong>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-glattmuskul\u00e4re Antik\u00f6rper (SMA): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Hochsensitiv.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">IgG:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Stark erh\u00f6ht, ein Schl\u00fcsselmarker.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Leberwerte (ALT, AST): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Typisch stark erh\u00f6ht.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-SLA\/LP: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Kann zus\u00e4tzlich getestet werden.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Hashimoto-Thyreoiditis<\/span><\/strong><\/p>\n<ul>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Mit ANA assoziiert: <\/span><\/strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">ANA sind bei etwa 20-50% der Patienten nachweisbar. Hashimoto ist eine chronische Autoimmunthyreoiditis, die zu Hypothyreose f\u00fchren kann.<\/span><\/li>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zus\u00e4tzliche Blutwerte:<\/span><\/strong>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-TPO (Thyreoperoxidase-Antik\u00f6rper): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Typisch f\u00fcr Hashimoto.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-Tg (Thyreoglobulin-Antik\u00f6rper): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">H\u00e4ufig erh\u00f6ht.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">TSH, fT4, fT3:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Zur Beurteilung der Schilddr\u00fcsenfunktion.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Morbus Basedow<\/span><\/strong><\/p>\n<ul>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Mit ANA assoziiert: <\/span><\/strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">ANA k\u00f6nnen bei bis zu 20% der Patienten nachweisbar sein. Es handelt sich um eine Autoimmunerkrankung, die Hyperthyreose verursacht.<\/span><\/li>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zus\u00e4tzliche Blutwerte:<\/span><\/strong>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">TSH-Rezeptor-Antik\u00f6rper (TRAK): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Spezifisch f\u00fcr Morbus Basedow.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-TPO: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">H\u00e4ufig erh\u00f6ht.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">TSH, fT4, fT3:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Typisch f\u00fcr Hyperthyreose ver\u00e4ndert.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Pulmonale arterielle Hypertonie (PAH) und Lungenfi-brose<\/span><\/strong><\/p>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"><strong>Mit ANA assoziiert:<\/strong> <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">ANA sind bei 20-40% der Patienten positiv, besonders wenn eine zugrunde liegende Autoimmunerkrankung vorliegt (z. B. systemische Sklerose).<\/span><\/li>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zus\u00e4tzliche Blutwerte:<\/span><\/strong>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-Scl-70:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Kann bei Lungenfibrose positiv sein.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-Ro\/SSA:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Assoziiert mit interstitiellen Lungenerkrankungen.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">BNP oder NT-proBNP: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zur \u00dcberwachung von Herzbelastungen.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Lungenfunktionstests: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zur Beurteilung der Lungenkapazit\u00e4t.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Prim\u00e4r bili\u00e4re Cholangitis (PBC)<\/span><\/strong><\/p>\n<ul>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Mit ANA assoziiert: <\/span><\/strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">ANA sind bei nahezu 100% der Patienten nachweisbar, h\u00e4ufig in Form eines zentromerischen Musters.<\/span><\/li>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zus\u00e4tzliche Blutwerte:<\/span><\/strong>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-Mitochondrien-Antik\u00f6rper (AMA): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Hochspezifisch f\u00fcr PBC.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">IgM: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Typisch erh\u00f6ht bei PBC.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Leberwerte (ALP, Bilirubin): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Charakteristisch stark erh\u00f6ht.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">GGT: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zur Beurteilung der Gallengangsbeteiligung.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Rheumatoide Arthritis (RA)<\/span><\/strong><\/p>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"><strong>Mit ANA assoziiert:<\/strong> <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">ANA sind bei etwa 30% der Patienten positiv, jedoch weniger spezifisch als andere Marker. RA betrifft prim\u00e4r die Gelenke, kann jedoch systemische Manifestationen wie Lungen- oder Herzbeteiligung aufweisen.<\/span><\/li>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zus\u00e4tzliche Blutwerte:<\/span><\/strong>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-CCP (zyklische citrullinierte Peptide):<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Hoch spezifisch und ein Fr\u00fchmarker der Erkrankung.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Rheumafaktor (RF): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">H\u00e4ufig positiv, jedoch weniger spezifisch.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">CRP und BSG:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Zeigen die Entz\u00fcndungsaktivit\u00e4t an.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-MCV: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Ein zus\u00e4tzlicher Marker, besonders bei seronegativer RA.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Bildgebung (z. B. R\u00f6ntgen, MRT): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zur Beurteilung von Gelenkzerst\u00f6rungen.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Thyreoiditis<\/span><\/strong><\/p>\n<ul>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Mit ANA assoziiert: <\/span><\/strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Bei autoimmunen Schilddr\u00fcsener-krankungen wie Hashimoto oder Basedow k\u00f6nnen ANA bei 30-50% der Patienten positiv sein.<\/span><\/li>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zus\u00e4tzliche Blutwerte:<\/span><\/strong>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-TPO:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Erh\u00f6ht bei Hashimoto und Basedow.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">TSH, fT4, fT3:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Zur Beurteilung der Schilddr\u00fcsenfunktion.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-Tg:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> H\u00e4ufig positiv bei autoimmuner Thyreoiditis.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>2.<span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Mit ANA assoziierte <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Kollagenosen<\/span><\/strong><\/p>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Mixed Connective Tissue Disease (MCTD)<\/span><\/strong><\/p>\n<ul>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Mit ANA assoziiert: <\/span><\/strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">ANA sind bei nahezu 100% der Patienten positiv. Typisch ist ein feink\u00f6rniges (speckled) Fluoreszenzmuster.<\/span><\/li>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zus\u00e4tzliche Blutwerte:<\/span><\/strong>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-RNP:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Essenziell f\u00fcr die Diagnose von MCTD.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Komplementfaktoren (C3, C4): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">K\u00f6nnen bei aktiver Erkrankung vermindert sein.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Entz\u00fcndungsmarker (CRP, BSG): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">H\u00e4ufig erh\u00f6ht.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Organ-spezifische Tests: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Lungenfunktionstests bei Verdacht auf pulmonale Hypertonie.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Systemischer Lupus erythematodes (SLE)<\/span><\/strong><\/p>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"><strong>Mit ANA assoziiert:<\/strong> <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">ANA sind bei 95-100% der Patienten nachweisbar. Ein homogenes ANA-Muster ist typisch, aber nicht exklusiv.<\/span><\/li>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zus\u00e4tzliche Blutwerte:<\/span><\/strong>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-dsDNA: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Hoch spezifisch, besonders bei Lupusnephritis.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-Sm: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Marker f\u00fcr SLE, jedoch seltener.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Komplementfaktoren (C3, C4): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Verminderte Werte k\u00f6nnen auf Krankheitsaktivit\u00e4t hinweisen.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Antiphospholipid-Antik\u00f6rper: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Bei thrombotischen Komplikationen h\u00e4ufig erh\u00f6ht.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">CRP und BSG: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">BSG h\u00e4ufig erh\u00f6ht, CRP meist nur bei sekund\u00e4ren Infektionen.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Systemische Sklerose (Sklerodermie)<\/span><\/strong><\/p>\n<ul>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Mit ANA assoziiert:<\/span><\/strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> ANA sind bei 95% der Patienten positiv. Nukleol\u00e4res oder zentromerisches Muster h\u00e4ufig.<\/span><\/li>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zus\u00e4tzliche Blutwerte:<\/span><\/strong>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-Scl-70: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Typisch f\u00fcr die diffuse Form der Sklerodermie, assoziiert mit Lungenfibrose.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-Zentromer:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Marker f\u00fcr die limitierte Form (CREST-Syndrom).<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">NT-proBNP:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Zur Beurteilung einer m\u00f6glichen Herzbeteiligung.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Lungenfunktionstests: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zur Abkl\u00e4rung einer interstitiellen Lungenerkrankung.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Entz\u00fcndungsmarker (CRP, BSG): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Erh\u00f6ht bei systemischen Entz\u00fcndungen.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Sj\u00f6gren-Syndrom<\/span><\/strong><\/p>\n<ul>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Mit ANA assoziiert:<\/span><\/strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> ANA sind bei ca. 90% der Patienten positiv, h\u00e4ufig mit Anti-Ro\/SSA und Anti-La\/SSB.<\/span><\/li>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zus\u00e4tzliche Blutwerte:<\/span><\/strong>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Anti-Ro\/SSA und Anti-La\/SSB: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Typisch f\u00fcr Sj\u00f6gren-Syndrom.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Rheumafaktor (RF): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">H\u00e4ufig positiv, selbst ohne rheumatoide Arthritis.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Hypergammaglobulin\u00e4mie: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Nachweisbar durch Serum-Protein-Elektrophorese.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Schirmer-Test: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zur Bewertung der Tr\u00e4nenproduktion.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Speicheldr\u00fcsenbiopsie: <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Zur Sicherung der Diagnose bei unklaren F\u00e4llen.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>3.<span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Mit ANA assoziierte <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Vaskulitiden<\/span><\/strong><\/p>\n<p><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">ANA k\u00f6nnen bei einigen Vaskulitiden positiv sein, sind jedoch nicht spezifisch. Vaskulitiden entstehen durch eine Fehlsteuerung des Immunsystems, das die Gef\u00e4\u00dfw\u00e4nde angreift.<\/span><\/p>\n<p><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Beispiele und spezifische Marker:<\/span><\/strong><\/p>\n<ul>\n<li><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Granulomat\u00f6se Polyangiitis (ehemals Wegener-Granulomatose):<\/span><\/strong>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">ANCA (c-ANCA, PR3): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Spezifisch f\u00fcr die Erkrankung.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">CRP und BSG:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> H\u00e4ufig erh\u00f6ht bei Entz\u00fcndungen.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Komplementfaktoren: K\u00f6nnen bei systemischen Entz\u00fcndungen ver\u00e4ndert sein.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Mikroskopische Polyangiitis:<\/span><\/strong><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">ANCA (p-ANCA, MPO): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Typisch f\u00fcr die Erkrankung.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Nierenwerte (Kreatinin, Harnstoff): Zur Beurteilung einer Glomerulonephritis.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"><strong>Churg-Strauss-Syndrom (eosinophile Granulomatose mit Polyangiitis):<\/strong><\/span><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">ANCA:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Oft p-ANCA assoziiert, jedoch nicht in allen F\u00e4llen positiv.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Eosinophile im Blut:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Typisch stark erh\u00f6ht.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">I<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">gE:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> H\u00e4ufig erh\u00f6ht, besonders bei Allergie-assoziierten Formen.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Takayasu-Arteriitis:<\/span><\/strong><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Entz\u00fcndungsmarker (CRP, BSG): <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Starke Erh\u00f6hung bei aktiver Entz\u00fcndung.<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Angiographie:<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> Zur Beurteilung von Gef\u00e4\u00dfver\u00e4nderungen.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>4.<span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Mit ANA assoziierte <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Infektionen, Neubildungen &amp; andere Erkrankungen<\/span><\/strong><\/p>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Infektionen (viral, bakteriell):<\/span><\/strong><\/p>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Epstein-Barr-Virus, HIV, Hepatitis-C-Virus, Parvovirus B19<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">subakute bakterielle Endokarditis<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Syphilis<\/span><\/li>\n<\/ul>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Neubildungen:<\/span><\/strong><\/p>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">hepatozellul\u00e4res Karzinom (HCC;<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">prim\u00e4res Leberzellkarzinom) (ca. 30 %);<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">lymphoproliferative Erkrankungen;<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">paraneoplastische Syndrome<\/span><\/li>\n<\/ul>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Andere Krankheiten:<\/span><\/strong><\/p>\n<ul>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">chronisch-entz\u00fcndliche Darmerkrankungen (CED);<\/span><\/li>\n<li><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">idiopathische Lungenfibrose (IPF)<\/span><\/li>\n<\/ul>\n<p>\u00a0<\/p>\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wenn trotz negativem ANA-Wert eindeutige Symptome einer erkrankung vorliegen, muss tiefergehend gesucht werden. Um einen \u00dcberblick zu erhalten, welche m\u00f6glichkeiten noch bestehen, um mit ANA assoziierte Erkrankungen nachzuweisen habe ich &#8230;<\/p>\n","protected":false},"author":1,"featured_media":562,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23],"tags":[],"class_list":["post-943","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-rheuma-blutwerte"],"_links":{"self":[{"href":"https:\/\/psoriasisarthritis.ch\/index.php?rest_route=\/wp\/v2\/posts\/943","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/psoriasisarthritis.ch\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/psoriasisarthritis.ch\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/psoriasisarthritis.ch\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/psoriasisarthritis.ch\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=943"}],"version-history":[{"count":3,"href":"https:\/\/psoriasisarthritis.ch\/index.php?rest_route=\/wp\/v2\/posts\/943\/revisions"}],"predecessor-version":[{"id":947,"href":"https:\/\/psoriasisarthritis.ch\/index.php?rest_route=\/wp\/v2\/posts\/943\/revisions\/947"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/psoriasisarthritis.ch\/index.php?rest_route=\/wp\/v2\/media\/562"}],"wp:attachment":[{"href":"https:\/\/psoriasisarthritis.ch\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=943"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/psoriasisarthritis.ch\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=943"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/psoriasisarthritis.ch\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=943"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}